Cardiovascular Diabetology

Article	Citations
Correlation between the triglyceride-glucose index and left ventricular global longitudinal strain in patients with chronic heart failure: a cross-sectional study	451
Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies	366
Obesity-induced mesenteric PVAT remodelling is sexually dimorphic, but not driven by ovarian hormones	253
Proteinuria and the risk of Incident atrial fibrillation according to glycemic stages: a nationwide population-based cohort study	237
Correction: Excessive occupational sitting increases risk of cardiovascular events among working individuals with type 1 diabetes in the prospective Finnish Diabetic Nephropathy Study	203
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database	189
Cellular crosstalk in organotypic vasculature: mechanisms of diabetic cardiorenal complications and SGLT2i responses	169
Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40–65: a prospective cross	161
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report	159
The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: evi	158
Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus	158
Influence of diabetes on mortality and ICD therapies in ICD recipients: a systematic review and meta-analysis of 162,780 patients	147
Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population	142
Correction: Multi-modal characterisation of early-stage, subclinical cardiac deterioration in patients with type 2 diabetes	137
Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes	135
Association between the cumulative estimated glucose disposal rate and incident cardiovascular disease in individuals over the age of 50 years and without diabetes: data from two large cohorts in Chin	119
Correction: Relationship between changes in the triglyceride glucose-body mass index and frail development trajectory and incidence in middle-aged and elderly individuals: a national cohort study	118
A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction	118
Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort	108
Diabetes mellitus is associated to high-risk late gadolinium enhancement and worse outcomes in patients with nonischemic dilated cardiomyopathy	107
Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes	106
Surgical treatment on infective endocarditis: impact of diabetes on mortality	102
Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus	100
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial	99
Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention	97

In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation	94
The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study	94
In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure	94
The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis	94
Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status	93
Impact of glycemic control metrics on short- and long-term mortality in transcatheter aortic valve replacement patients: a retrospective cohort study from the MIMIC-IV database	91
Associations of phosphorus concentrations with medial arterial calcification in lower-extremity arteries and diabetic foot in people with diabetes: a retrospective cross-sectional study	90
Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study	86
Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes	86
Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes	84
Validation of an early vascular aging construct model for comprehensive cardiovascular risk assessment using external risk indicators for improved clinical utility: data from the EVasCu study	84
MAP4K4 exacerbates cardiac microvascular injury in diabetes by facilitating S-nitrosylation modification of Drp1	82
The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disea	82
Sex-related disparities in the incidence and outcomes of infective endocarditis according to type 2 diabetes mellitus status in Spain, 2016–2020	80
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease	79
The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study	79
Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA	77
Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study	77
Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography	77
Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach	76
Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension	74
Short and long-term prognosis of admission hyperglycemia in patients with and without diabetes after acute myocardial infarction: a retrospective cohort study	73
Age-dependent effects of SGLT2 inhibitors on stroke risk in geriatric patients with diabetes and atrial fibrillation	72
Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community	71
Prediabetes as a risk factor for new-onset atrial fibrillation: the propensity-score matching cohort analyzed using the Cox regression model coupled with the random survival forest	71
Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a mendelian randomization study of European ancestry	70
Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics	70
Impact of early postoperative blood glucose variability on serum endocan level in cardiac surgery patients: a sub study of the ENDOLUNG observational study	70
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)	70
Longitudinal DNA methylation profiles in saliva of offspring from mothers with gestational diabetes: associations with early childhood growth patterns	70
Association of insulin resistance surrogates with disease severity and adverse outcomes in chronic thromboembolic pulmonary hypertension: a multicenter cohort study	68
Phenotype-based clusters, inflammation and cardiometabolic complications in older people before the diagnosis of type 2 diabetes: KORA F4/FF4 cohort study	68
Association of body composition with left ventricular remodeling and outcomes in diabetic heart failure with reduced ejection fraction: assessment of sarcopenic obesity using cardiac MRI	67
Combined risk estimates of diabetes and coronary angiography-derived index of microcirculatory resistance in patients with non-ST elevation myocardial infarction	67
Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall—a sub-analysis of the UTOPIA trial	63
Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes	63
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes	63
Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease	61
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease	61
Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism	60
Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes	60
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes	59
The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis	59
Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes	58
Transcriptome wide changes in long noncoding RNAs in diabetic ischemic heart disease	58
Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study	57
The potential anti-arrhythmic effect of SGLT2 inhibitors	54
Compromised cardiac autonomic function in non-diabetic subjects with 1 h post-load hyperglycemia: a cross-sectional study	53
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial	52
Identification of regulatory networks and crosstalk factors in brown adipose tissue and liver of a cold-exposed cardiometabolic mouse model	52

Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism	51
Evaluating sex-specific responses to western diet across the lifespan: impact on cardiac function and transcriptomic signatures in C57BL/6J mice at 530 and 640/750 days of age	50
Identification of potential therapeutic targets for nonischemic cardiomyopathy in European ancestry: an integrated multiomics analysis	50
Assessing coronary artery stenosis exacerbated impact on left ventricular function and deformation in metabolic syndrome patients by 3.0 T cardiac magnetic resonance imaging	50
Comprehensive echocardiographic and biomarker assessment of patients with diabetic ketoacidosis	50
Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data	50
Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies	50
Sex-related disparities in the incidence and outcomes of hemorrhagic stroke among type 2 diabetes patients: a propensity score matching analysis using the Spanish National Hospital Discharge Database	49
Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study	49
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND	49
Correction to: Association between carotid plaque vulnerability and high mobility group box‑1 serum levels in a diabetic population	48
FGF21/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China	48
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease	48
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data	47
Visit-to-visit fasting blood glucose variability and lifetime risk of cardiovascular disease: a prospective study	47
Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study	46
Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c	46
Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence	46
The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease, regardless of diabetes mellitus and hyperlipidaemia	46
J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention	46
Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) pros	46
Association of prior outpatient diabetes screening with cardiovascular events and mortality among people with incident diabetes: a population-based cohort study	46
Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes	46
Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial	46
Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes	46
An innovative model for predicting coronary heart disease using triglyceride-glucose index: a machine learning-based cohort study	46
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness an	46
BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity	45
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart P	45
Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project	44
Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort	44
Prediabetes increases the risk of major limb and cardiovascular events	43
Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry	43
Dual roles of myocardial mitochondrial AKT on diabetic cardiomyopathy and whole body metabolism	43
Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target t	43
Non-invasive detection of early microvascular changes in juveniles with type 1 diabetes	43
Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes	42
Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular disease	42
Impact of pretransplant T2DM on left ventricular deformation and myocardial perfusion in heart transplanted recipients: a 3.0 T cardiac magnetic resonance study	42
Association between triglyceride–glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation	42
Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke	41
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity	41
The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study	41
Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses	41
CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients	40
Association between triglyceride glucose index and atherosclerotic plaques and Burden: findings from a community-based study	40
The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7	40
Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography	40
Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink‐6 randomized clinical trial	39
Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: risk of heart failure	39
Identifying metabotypes of insulin resistance severity in children with metabolic syndrome	39
Association of atherogenic index of plasma trajectory with the incidence of cardiovascular disease over a 12-year follow-up: findings from the ELSA cohort study	38
Low total osteocalcin levels are associated with all-cause and cardiovascular mortality among patients with type 2 diabetes: a real-world study	38
The impact of hypercortisolism beyond metabolic syndrome on left ventricular performance: a myocardial work analysis	38
The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4	37
Remnant lipoprotein cholesterol is associated with incident new onset diabetes after transplantation (NODAT) in renal transplant recipients: results of the TransplantLines Biobank and cohort Studies	37
A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus under	37
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride	37
The link between gestational diabetes and cardiovascular diseases: potential role of extracellular vesicles	37
Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation	37
Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis	36
Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case–control study from the PARADIG	36
Comparison of the effects of triglyceride variability and exposure estimate on clinical prognosis in diabetic patients	36
Polygenic scores for low lung function and the future risk of adverse health outcomes	36
Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke	36
Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study	36
Immune-inflammatory biomarkers and the risk of cardiac injury in COVID-19 patients with diabetes: a retrospective cohort study	36
Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes	35
Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank	35
Long-term increase in fasting blood glucose is associated with increased risk of sudden cardiac arrest	35
Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study	35
Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy	35
Early longitudinal changes in left ventricular function and morphology in diabetic pigs: evaluation by 3.0T magnetic resonance imaging	35
Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review	35
Glyoxal in hyperglycaemic ischemic stroke – a cohort study	34
Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study	34
Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease	34
Deep-learning prediction of cardiovascular outcomes from routine retinal images in individuals with type 2 diabetes	34
Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation	33
Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction	33

Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults	33
High proportion of undiagnosed diabetes in patients surgically treated for infrarenal abdominal aortic aneurysm: findings from the multicentre Norwegian Aortic Aneurysm and Diabetes (ABANDIA) Study	33
Association of metabolic syndrome severity with frailty progression among Chinese middle and old-aged adults: a longitudinal study	33
Metabolic syndrome parameters' variability and stroke incidence in hypertensive patients: evidence from a functional community cohort	33
Relationship between stress hyperglycemia ratio and acute kidney injury in patients with congestive heart failure	33
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfun	33
Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes	33
The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes	32
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review	32
Impact of red cell distribution width and red cell distribution width/albumin ratio on all-cause mortality in patients with type 2 diabetes and foot ulcers: a retrospective cohort study	32
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension s	32
Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease: an observational, register-based cohort study	32
Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention	32
TyGIS: improved triglyceride-glucose index for the assessment of insulin sensitivity during pregnancy	32
Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide	31
Association of long-term triglyceride-glucose index patterns with the incidence of chronic kidney disease among non-diabetic population: evidence from a functional community cohort	31
Correction: L-Arginine in diabetes: clinical and preclinical evidence	31
Correction: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials	31
Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease	31
High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies	30
Correction to: Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists	30
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better	30
Association of triglyceride-glucose index trajectory and frailty in urban older residents: evidence from the 10-year follow-up in a cohort study	30
Nonpharmacological interventions on glycated haemoglobin in youth with type 1 diabetes: a Bayesian network meta-analysis	30
Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network	30
Correction: Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status	30
Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm	29
Investigating sex-specific associations of lipid traits with type 2 diabetes, glycemic traits and sex hormones using Mendelian randomization	29
Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study	29
A high-volume study on the impact of diabetes mellitus on clinical outcomes after surgical and percutaneous cardiac interventions	29
N6-Methyladenosine-mediated phase separation suppresses NOTCH1 expression and promotes mitochondrial fission in diabetic cardiac fibrosis	29
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance	29
The triglyceride–glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning ana	29
Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery	29
Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT	29
The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy	29
Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart	28
Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort s	28
Combined impact of prediabetes and hepatic steatosis on cardiometabolic outcomes in young adults	28
Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration	28
Diabetes and restenosis	28
Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis	28
Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study	28
The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China	28
Visceral adipose tissue is an independent predictor and mediator of the progression of coronary calcification: a prospective sub-analysis of the GEA study	28
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide	28
Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population	28
Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study	27
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs	27
Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction	27
Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis	27
Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study	27
Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy	27
Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fraction	27
Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-A study based on the MIMIC-IV database	27
Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives	27
Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database	27
Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from american MIMIC-IV and the chinese CIN-II study	27
Lessons from PROMINENT and prospects for pemafibrate	27
Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database	26
CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus	26
The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database	26
ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice	26
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist	26
Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA/p47PHOX mediated ferroptosis	26
Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study	26
Impact of hypoglycemia at the time of hospitalization for heart failure from emergency department on major adverse cardiovascular events in patients with and without type 2 diabetes	26
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes	26
High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study	25
Nonlinear relationship between untraditional lipid parameters and the risk of prediabetes: a large retrospective study based on Chinese adults	25
Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort	25
Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999–2018	25
Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease	25
Landscape of cardiometabolic risk factors in Chinese population: a narrative review	25
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia	25
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus	25
Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance	25
Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial	24
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management	24
Impact of T2DM on right ventricular systolic dysfunction and interventricular interactions in patients with essential hypertension: evaluation using CMR tissue tracking	24
Association between triglyceride–glucose index and mortality in critically ill patients with atrial fibrillation: a retrospective cohort study	24
Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states	24
Gender differences in the relationship between serum uric acid and the long-term prognosis in heart failure: a nationwide study	24
High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study	24
Left atrioventricular interaction and impaired left atrial phasic function in type 2 diabetes mellitus patients with or without anemia: a cardiac magnetic resonance study	24
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis	24
Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention	24
Association of TyG index and TG/HDL-C ratio with arterial stiffness progression in a non-normotensive population	23
Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis	23
The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease	23
Variability of risk factors and diabetes complications	23
Roles of non-coding RNA in diabetic cardiomyopathy	23
Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study	23
Association between the triglyceride-glucose index and carotid plaque incidence: a longitudinal study	23
Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit	23